RBC Capital Markets analysts raised the price target for Webster Financial Corporation, traded on the New York Stock Exchange ...

Financial-services firm RBC downgraded CF Industries from Outperform to Sector Perform, citing fair valuation and potential ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research Report), with a ...

RBC Capital Markets upgrades Bank of Montreal and Canadian Imperial Bank of Commerce to Outperform, citing positive outlook ...

Mr. John Puig is a Managing Director in the New York City and Albany Municipal Finance offices of RBC Capital Markets. He serves as the Head of the Northeast Large Issuer Practice Group and is a ...

RBC Capital analyst Gerard Cassidy maintained a Buy rating on Regions Financial (RF – Research Report) on January 17 and set a price target of ...

RBC Capital Markets lowered its price target for Nike Inc (NYSE:NKE) to $70 from $80 on the prolonged challenges in the company’s turnaround efforts. While the brokerage maintained its "sector perform ...

Critchley’s departure coincided with that of Dave Thomas, who retired as CEO of RBC Capital Markets Europe at the end of the ...